XML 40 R29.htm IDEA: XBRL DOCUMENT v3.26.3
Net Loss per Common Share
9 Months Ended
Sep. 30, 2026
Earnings Per Share [Abstract]  
Net Loss per Common Share Net Loss per Common Share
The following table provides the basic and diluted net loss per common share computations for the three and nine months ended September 30, 2026 and 2025.
Table 21.1 – Basic and Diluted Net Loss per Common Share
Three Months Ended September 30,Nine Months Ended September 30,
(In Thousands, except Share Data)2026202520262025
Basic Net Loss per Common Share:
Net loss related to common stockholders$(47,255)$(9,454)$(57,366)$(95,306)
Less: Dividends and undistributed earnings allocated to participating securities(1,420)(1,360)(4,137)(4,185)
Net loss related to common stockholders$(48,675)$(10,814)$(61,503)$(99,491)
Basic weighted average common shares outstanding124,121,653 129,018,261 124,739,102 131,583,195 
Basic Net Loss per Common Share$(0.39)$(0.08)$(0.49)$(0.76)
Diluted Net Loss per Common Share:
Net loss related to common stockholders$(47,255)$(9,454)$(57,366)$(95,306)
Less: Dividends and undistributed earnings allocated to participating securities(1,420)(1,360)(4,137)(4,185)
Net loss related to common stockholders$(48,675)$(10,814)$(61,503)$(99,491)
Weighted average common shares outstanding124,121,653 129,018,261 124,739,102 131,583,195 
Net effect of dilutive equity awards— — — — 
Diluted weighted average common shares outstanding124,121,653 129,018,261 124,739,102 131,583,195 
Diluted Net Loss per Common Share$(0.39)$(0.08)$(0.49)$(0.76)
We included participating securities, which are certain equity awards that have non-forfeitable dividend participation rights, in the calculations of basic and diluted net loss per common share as we determined that the two-class method was more dilutive than the alternative treasury stock method for these shares. Dividends and undistributed earnings allocated to participating securities under the basic and diluted net loss per share calculations require specific shares to be included that may differ in certain circumstances.
During the three and nine months ended September 30, 2026 and 2025, our convertible senior notes (and, for 2025, our exchangeable senior notes) were not determined to be dilutive and were not included in the calculation of diluted EPS under the "if-converted" method. Under this method, for convertible notes due in 2027 and 2030, if the potential conversion of the debt is dilutive, then the number of shares needed to settle the conversion premium are added to the shares outstanding used to calculate dilutive EPS.
During the three and nine months ended September 30, 2026, none of our Warrants were determined to be dilutive to our calculation of dilutive net loss per common share. The Warrants would have a dilutive effect on net loss per common share to the extent that the Warrants are vested and exercisable, and the average market value per share of our common stock exceeds the strike price of the Warrants.
For both the three and nine months ended September 30, 2026, 33,982,388 and 30,303,726 of common shares related to the assumed conversion of our convertible senior notes, were antidilutive and were excluded in the calculation of diluted net loss per share, respectively. For both the three and nine months ended September 30, 2025, 32,403,083 and 31,127,434 of common shares related to the assumed conversion of our convertible senior notes and our exchangeable senior notes, were antidilutive and were excluded in the calculation of diluted net loss per share, respectively.
For the three and nine months ended September 30, 2026, the number of outstanding equity awards that were antidilutive totaled 22,145 and 65,213 common shares, respectively. For the three and nine months ended September 30, 2025, the number of outstanding equity awards that were antidilutive totaled 20,938 and 66,185 common shares, respectively.
For additional information regarding EPS, see Note 21 to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended December 31, 2025.